A detailed history of Sentinus, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sentinus, LLC holds 5,559 shares of JNJ stock, worth $864,257. This represents 0.28% of its overall portfolio holdings.

Number of Shares
5,559
Previous 5,083 9.36%
Holding current value
$864,257
Previous $804,000 1.0%
% of portfolio
0.28%
Previous 0.29%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $68,724 - $75,103
476 Added 9.36%
5,559 $812,000
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $39,425 - $41,335
-254 Reduced 4.76%
5,083 $804,000
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $76,866 - $82,722
498 Added 10.29%
5,337 $883,000
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $482,604 - $575,930
3,195 Added 194.34%
4,839 $750,000
Q4 2022

Feb 15, 2023

BUY
$160.2 - $179.79 $160 - $179
1 Added 0.06%
1,644 $290,000
Q3 2022

Nov 16, 2022

BUY
$161.33 - $179.52 $265,065 - $294,951
1,643 New
1,643 $268,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sentinus, LLC Portfolio

Follow Sentinus, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentinus, LLC with notifications on news.